Fundraising Fox

Variant Bio

New York, US · Founded 2018 · Delaware corporation · 4 known investors

Biotech company focused on discovery of novel medicines.

Biotechin /variantbio@VariantBio

Founders & leadership

JS
Julie SunderlandDirector
JW
Josh WolfeDirector
KW
Kaja WasikExecutive Officer, Director
AF
Andrew FarnumExecutive Officer, Director
BM
Bob MoreDirector

Investors · 4

Alta PartnersJackson · $1M – $12M
General CatalystSan Francisco · $30M
Lux CapitalNew York · $100K – $100M
Dimension CapitalreportedSan Francisco · $1M – $10Mvia Adam Goulburn · board

Reported raises · per SEC filings

Form D private placements
▶$105MraisedNov 2021 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Stuart NagaeDirector
  • Bob MoreDirector
  • Andrew FarnumExecutive Officer, Director
  • Elena VibochDirector
  • Josh WolfeDirector
  • Stephane CastelExecutive Officer, Director
  • Julie SunderlandDirector
Offering amount
$105M
Amount sold
$105M
First sale
Oct 2021
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.1MraisedAug 2020 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Julie SunderlandDirector
  • Josh WolfeDirector
  • Bob MoreDirector
  • Kaja WasikExecutive Officer, Director
  • Andrew FarnumExecutive Officer, Director
Offering amount
$6.7M
Amount sold
$6.1M
First sale
Jul 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$16.6MraisedOct 2019 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kaja WasikDirector
  • Akhila KosarajuExecutive Officer, Director
  • Adam GoulburnDirector
  • Josh WolfeExecutive Officer, Director
Offering amount
$31.5M
Amount sold
$16.6M
First sale
Sep 2019
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.